Astrea Bioseparations
Astrea Bioseparations appears in 1 markets tracked by Meridian Consensus across 1 industry (Healthcare). Aggregate market exposure is $34M, computed as the sum of (share × market size) across every appearance.
Its strongest position is Affinity Chromatography Market at 0.8% share in a market growing at 7.2% CAGR. Average share across all tracked markets is 0.8%, indicating a diversified participant footprint.
Each market page below carries the full Porter Five Forces, SWOT, regional sub-data, regulatory landscape, and competitor table the operator competes against. Use the related-operator rail at the bottom of the page to triangulate Astrea Bioseparations against the peers it actually overlaps with in those segments.
Market positions
Avg share 0.8% · sorted by exposure| Market | Market size | Share | Exposure |
|---|---|---|---|
| Affinity Chromatography Market | $4.2B | 0.8% |
Explore adjacent markets
Each market page surfaces Porter Five Forces, SWOT, country analysis, patent filings, regulatory signals, and more, verified against SEC filings, FRED macro series, and trade-association benchmarks.
Operators that compete with Astrea Bioseparations
Peers that show up alongside Astrea Bioseparations in the markets above. Ordered by how many overlapping markets they share — the top of the list is who the operator competes against most directly.